Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms

Archive ouverte

Couturaud, Francis | Bertoletti, Laurent | Pastre, Jean | Roy, Pierre-Marie | Le Mao, Raphael | Gagnadoux, Frédéric | Paleiron, Nicolas | Schmidt, Jeannot | Sanchez, Olivier | de Magalhaes, Elodie | Kamara, Mariam | Hoffmann, Clément | Bressollette, Luc | Nonent, Michel | Tromeur, Cécile | Salaun, Pierre-Yves | Barillot, Sophie | Gatineau, Florence | Mismetti, Patrick | Girard, Philippe | Lacut, Karine | Lemarié, Catherine | Meyer, Guy | Leroyer, Christophe

Edité par CCSD ; American Medical Association -

International audience. Background Information is lacking as to the management of patients with superficial venous thrombosis (SVT) whose profile has been excluded from trials, such as patients with active cancer, severe renal impairment, or pregnancy. Objectives To describe the frequency and management of SVT occurring in these situations. Methods We retrospectively analyzed the frequency, management and evolution of all patients with isolated SVT associated with either active cancer, severe renal impairment, or pregnant or postpartum women, diagnosed in 2 university hospital between January 1st, 2015 and December 31st, 2016. Results Of the 594 isolated SVTs individualized from the 7941 reports screened, 149 SVTs (105 in the upper extremity, 44 in the lower extremity) were analyzed: 94 (63%) associated with active cancer, 27 (18%) with severe renal impairment and 30 (20%) pregnant or postpartum women. SVT was treated with anticoagulant in 34 (36%) patients with cancer, 3 (11%) patients with severe renal impairment and 19 (63%) pregnant or postpartum women. At 3-month, 16 patients (10.8%) had a further venous thromboembolic event, 8 (5.4%) major bleeding, and 9 (6.1%) died. Conclusion SVT in patients with active cancer, severe renal impairment and pregnant or postpartum women represents a quarter of isolated SVTs diagnosed. Heterogeneity of treatment patterns mainly affects patients with cancer and severe renal impairment. Poor outcomes, although probably linked to morbidity, call for dedicated research in these specific situations.

Consulter en ligne

Suggestions

Du même auteur

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Archive ouverte | Couturaud, Francis | CCSD

International audience

Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial

Archive ouverte | Rambaud, Geoffroy | CCSD

International audience

Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: a post-hoc analysis of the PADIS-PE trial

Archive ouverte | Raj, Leela | CCSD

International audience. INTRODUCTION We aimed to validate the HERDOO2 DASH and Updated Vienna recurrent venous thromboembolism prediction models in a population composed entirely of first unprovoked pulmonary emboli...

Chargement des enrichissements...